Watchmaker Genomics, announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, for certain foundational CRISPR-Cas9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results